MJ5-16582-31457
3 vaccinations
1 coded response
9 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 777 / TX
- Registered
- 2021-11-25
- Relationship
- Adult relative or friend
- Guardian
- 3UA-51515-29043
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-05
Dose 1 — Moderna
-
2021-04-05
Dose 2 — Moderna
-
2021-11-19
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2021-11-25
Registered in v-safe
- 2021-11-25
- 2021-11-26
- 2021-12-04
- 2021-12-11
- 2021-12-17
- 2021-12-25
- 2021-12-31
-
2022-02-18
Survey response — 3 months, dose 3, dependentMedDRA: Pre-existing disease, Rheumatoid arthritis — Feeling: GoodFree text: Her rheumatoid arthritis seems to be acting up since she had her third vaccine shot, the booster. She received a booster for Moderna vaccine, and her arthritis started acting up shortly after the booster.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-05 | Moderna | No |
| 2 | 2021-04-05 | Moderna | No |
| 3 | 2021-11-19 | Pfizer-BioNTech | Flu |
Free text
Release 11 — 3 months, dose 3, dependent
Symptoms: Her rheumatoid arthritis seems to be acting up since she had her third vaccine shot, the booster. She received a booster for Moderna vaccine, and her arthritis started acting up shortly after the booster.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pre-existing disease | · | · | ✓ |
| SD | Rheumatoid arthritis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release